|
RU1781210C
|
|
Process for producing 2-hydroxy-5-@@@ 1-hydroxy-2-[n-(1-methyl-3-phenylpropyl)] aminoethyl @@@ benzamide hydrochloride
|
|
SU1699996A1
|
|
Method for preparation of n-benzoyl-@,@-dehydrophenylalanine dialkylaminoalkyl ethers
|
|
SU1582192A1
|
|
Method of determining effect of antidepressant
|
|
SU1066997A1
|
|
New heterocyclic triazaspiro-condensed systems
|
|
SU1016288A1
|
|
2,2-dialkyl-3thia-7,11-diazaspiro(5,6)dodecanes
|
|
SU1004386A1
|
|
Spiro-(2,2-dialkyltetrahydropyran-4,2-(1,2,4-tetrahydro)-quinaxolines)
|
|
SU1002294A1
|
|
2,2-dialkyl-3-tia-8-azaspiro-(5,5) undercanes
|
|
SU996417A1
|
|
8,8-dialkyl-9-thia-1,4-diazaspiro(5,5)-undecanes
|
|
SU1028335A1
|
|
Method of producing iridoide fraction having cap ability of increasing physical efficiency
|
|
SU941370A1
|
|
2,2-dialkyl-7-methyl-3-oxa-7,11-diazospiro (5,6)dodecanes
|
|
SU910637A1
|
|
3-(3-chloro-4-alkoxyphenyl)-5,6-dihydroimidazo-[2,1-b! tiazole hydrochlorides exhibiting mutagenic activity
|
|
SU937457A1
|
|
Process for producing substituted triazabicyclononanes
|
|
SU736583A1
|
|
1-(2-phenethyl)-2,5-dimethyl-4-n-propionyl-anilinopiperidine or its salts possessing analgetic effect and method of producing same
|
|
SU810699A1
|
|
Method of preparing 2,5-dimethyl-7-chloroxazolo/5,4-d/pyrimine
|
|
SU677301A1
|
|
N-(2-methyl-4-substituted benzenesulfonyl)-n'-butylurea (thiourea) possessing mutagenic activity
|
|
SU640992A1
|
|
2-isopropyl-5-methylcyclohexoxy(a,a'-dialkyl)methylpenicillines or their sodium salts possessing antibacterial effect
|
|
SU732250A1
|
|
Method of preparing beta -and beta-,beta-substituted alpha-phenylacrylonitriles
|
|
SU586163A1
|
|
Method of preparing n'-arylalkylamides of n-arylalkyl-substituted b-alanines
|
|
SU696009A1
|
|
3 -phenyl -3 -0 -oxyphenyl -n (phenylisopropyl) -propylamine or its salts exibiting vasodilating action
|
|
SU572045A1
|
|
3-(o-oxyphenyl)-3-phenylpropionic acid as intermediate product in synthesis of biologically active compounds and method of obtaining same
|
